Vildagliptin, a Dipeptidyl Peptidase-IV Inhibitor, Improves Model-Assessed β-Cell Function in Patients with Type 2 Diabetes

Mari et al. (Mon,) studied this question.

www.synapsesocial.com/papers/69de9730499d77a496b0bf57 — DOI: https://doi.org/10.1210/jc.2004-2460

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Estimation of Insulin Secretion Rates from C-Peptide Levels: Comparison of Individual and Standard Kinetic Parameters for C-Peptide Clearance· 1992 · 811 citations
2. Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM· 1997 · 1,613 citations
3. A Model-Based Method for Assessing Insulin Sensitivity From the Oral Glucose Tolerance Test· 2001 · 801 citations
4. Glucagon-Like Peptide-1 Augments Insulin-Mediated Glucose Uptake in the Obese State· 2002 · 25 citations
5. Characterization of GLP-1 Effects on β-Cell Function After Meal Ingestion in Humans· 2003 · 73 citations